Its proprietary and differentiated lipid nanoparticle (LNP) platform is a cornerstone in advancing next-generation messenger ...
If you think last week's decision by the federal government to halt $500 million in funding for vaccine development projects that use mRNA technology will only affect COVID vaccines, think again.
Lipid nanoparticles, such as the one shown in this illustration, are used as vehicles to deliver mRNA-based vaccines. The U.S. Department of Health and Human Services announced on Tuesday that it will ...
The United States is turning its back on what could be the greatest medical advance in a generation — vaccines made with messenger RNA, or mRNA, technology. The U.S. Department of Health and Human ...
Hosted on MSN
UPenn, where mRNA vaccine tech was pioneered, will not lose funding as feds cut $500M in mRNA grants
Researchers in Philadelphia reacted with alarm this week when the Department of Health and Human Services announced it is cutting $500 million in funding for mRNA vaccine development. But the cuts ...
Post pandemic, Moderna Inc. is broadening the applications of mRNA technology to cancer, rare diseases, latent viruses and respiratory viruses, “taking advantage” of the revenue generated by Spikevax ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback